PHIO PHARMACEUTICALS Trademark

Trademark Overview

On Monday, May 23, 2022, a trademark application was filed for PHIO PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the PHIO PHARMACEUTICALS trademark a serial number of 97423827. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, November 12, 2024. This trademark is owned by Phio Pharmaceuticals Corp.. The PHIO PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceuticals for use in the treatment of cancer
phio pharmaceuticals

General Information

Serial Number97423827
Word MarkPHIO PHARMACEUTICALS
Filing DateMonday, May 23, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTherapeutic pharmaceuticals for use in the treatment of cancer
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePhio Pharmaceuticals Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMARLBOROUGH, MA 01752

Trademark Events

Event DateEvent Description
Thursday, May 26, 2022NEW APPLICATION ENTERED
Thursday, May 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 10, 2023ASSIGNED TO EXAMINER
Monday, April 10, 2023NON-FINAL ACTION WRITTEN
Monday, April 10, 2023NON-FINAL ACTION E-MAILED
Monday, April 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 27, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, June 27, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, October 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 29, 2023FINAL REFUSAL WRITTEN
Wednesday, November 29, 2023FINAL REFUSAL E-MAILED
Wednesday, November 29, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, January 17, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, January 17, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, March 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 4, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, November 12, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, November 12, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 22, 2024ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Monday, April 22, 2024NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Monday, April 22, 2024ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

Related Keywords

pharmaceuticals phio cancer treatment therapeutic